🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks.Unlock full list

Walgreens to buy remaining stake in Shields Health for $1.37 billion

Published 09/20/2022, 09:16 AM
Updated 09/20/2022, 11:57 AM
© Reuters. FILE PHOTO: The Walgreens logo is seen outside the store in Times Square in New York, U.S., July 5, 2016.  REUTERS/Shannon Stapleton

(Reuters) -Walgreens Boots Alliance said on Tuesday it would buy the remaining stake in specialty pharmacy company Shields Health Solutions for $1.37 billion.

Walgreens last year spent $970 million to increase its stake in the company to 71%, with an option to acquire remaining equity interests in the future.

Specialty pharmacies are designed to deliver medications with unique handling, storage and distribution requirements, often for patients with complex conditions such as cancer, multiple sclerosis and rheumatoid arthritis.

© Reuters. FILE PHOTO: The Walgreens logo is seen outside the store in Times Square in New York, U.S., July 5, 2016.  REUTERS/Shannon Stapleton

Founded in 2012, Shields Health Solutions helps hospitals provide specialty pharmacy services.

Walgreens has been seeking to shift its focus beyond drugstores, and last year it raised its stake in primary care provider VillageMD to 63%.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.